Code intelligence

J30.2 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code J30.2.

Elevated code riskView ICD-10 detail

Signal breakdown

4 shown · 4 total in platform

Risk: Elevated
0

Critical

0%

4

High

100%

0

Routine

0%

0

Low

0%

New this month

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L40056: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — CGS

Policy LCD-L40056 · Allergy/Immunology

High

New AIT guidelines affect billing practices.

LCD L40046: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — Palmetto GBA

Policy LCD-L40046 · Allergy/Immunology

High

Prepare for new billing guidelines for Allergy Immunotherapy.

LCD L40050: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — Noridian

Policy LCD-L40050 · Allergy/Immunology

High

New AIT LCD may improve billing clarity and reimbursements.

Proposed LCD DL40052: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) — Noridian

Policy LCD-DL40052 · Allergy/Immunology

High

New LCD for Allergen Immunotherapy may impact billing.

Audit documentation

Building an audit file that includes J30.2?

The Tripwire Audit Pack exports 12 months of Allergy/Immunology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Allergy/Immunology audit pack — $349One-time purchase · not a subscription